Ledo Capital, LLC 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Nov 27, 2020
Insider Transaction Report
Form 4
Levy Noah G.
DirectorOther
Transactions
- Purchase
Common Stock
2020-11-24$3.65/sh+28,809$105,153→ 639,824 total(indirect: See footnote) - Purchase
Common Stock
2020-11-24$3.65/sh+40,278$147,015→ 879,283 total(indirect: See footnote)
Footnotes (2)
- [F1]The shares are directly held by NP. The general partner of the Funds is NCP. The general partner of NCP is Ledo. The investment manager to the Funds is Newtyn Management. The managing member of Newtyn Management and Ledo and the portfolio manager to the Funds is Mr. Levy. Each of Newtyn Management, Ledo, NCP and Mr. Levy disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- [F2]The shares are directly held Newtyn TE. The general partner of the Funds is NCP. The general partner of NCP is Ledo. The investment manager to the Funds is Newtyn Management. The managing member of Newtyn Management and Ledo and the portfolio manager to the Funds is Mr. Levy. Each of Newtyn Management, Ledo, NCP and Mr. Levy disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.